Key facts
- Elo Health’s last known valuation is $21.5M (Mar 2025).
- It has raised $17.7M across 2 recorded rounds; the latest was Seed Round ($3.5M) in Mar 2025.
- Notable investors include Calm Ventures, Octopus Ventures, NZVC, Tess Ventures, Ilkka Paananen — 20 tracked in total.
- Elo Health has filed 2 Form Ds with the SEC since 2023, most recently Mar 2025 ($3.5M sold to 75 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Elo Health
Funding rounds
2 roundsAbout Elo Health
Producer of personalized supplements intended to promote health and wellness. The company offers products that are calibrated for biomarkers and goals and are made using ingredients that are scientifically proven, enabling customers to adopt and stick to a healthy lifestyle.
- Sector
- Healthcare
- HQ
- West Yellowstone, MT, United States
- Founded
- 2020
- Employees
- 20
- Website
- elo.health/
- Ownership
- Privately Held (backing)
Elo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elo Health in its N-PORT filings yet. We sweep new filings monthly.